Novo Nordisk A/S DPO Ratio 2011-2026 | NVO

Annual DPO Ratio Novo Nordisk A/S

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	140	116	128	111	124	106	105	95.4

All numbers in DKK currency

Maximum	Minimum	Average
140	95.4	116

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	277	-	-24.86 %	$ 820 K	USA
Alnylam Pharmaceuticals ALNY	55	$ 327.75	-1.69 %	$ 42.9 B	USA
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Amphastar Pharmaceuticals AMPH	31.7	$ 21.62	-0.28 %	$ 1.01 B	USA
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
ContraFect Corporation CFRX	1.83 K	-	-5.16 %	$ 5.39 M	USA
Akebia Therapeutics AKBA	168	$ 1.41	-9.03 %	$ 363 M	USA
Aquestive Therapeutics AQST	395	$ 4.18	-1.5 %	$ 447 M	USA
Arcutis Biotherapeutics ARQT	133	$ 24.23	-1.42 %	$ 3.08 B	USA
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
BioDelivery Sciences International BDSI	96.3	-	-4.8 %	$ 255 M	USA
Autolus Therapeutics plc AUTL	9.57	$ 1.48	-0.67 %	$ 394 M	Britain
BeiGene, Ltd. BGNE	915	-	0.49 %	$ 251 B	Cayman-islands
Caladrius Biosciences CLBS	51.2	-	-16.75 %	$ 25.8 M	USA
Clearside Biomedical CLSD	1.67 K	-	-	$ 25.3 M	USA
Celldex Therapeutics CLDX	4.06 K	$ 33.44	-1.27 %	$ 2.22 B	USA
bluebird bio BLUE	182	-	-	$ 546 M	USA